|
Name |
3''-deoxy-6'-O-desmethylcandidusin B
|
Molecular Formula | C19H14O6 | |
IUPAC Name* |
3-(4-hydroxyphenyl)-4-methoxydibenzofuran-1,7,8-triol
|
|
SMILES |
COC1=C2C(=C(C=C1C3=CC=C(C=C3)O)O)C4=CC(=C(C=C4O2)O)O
|
|
InChI |
InChI=1S/C19H14O6/c1-24-18-11(9-2-4-10(20)5-3-9)6-15(23)17-12-7-13(21)14(22)8-16(12)25-19(17)18/h2-8,20-23H,1H3
|
|
InChIKey |
PLXYXSNSJXMTSA-UHFFFAOYSA-N
|
|
Synonyms |
3''-deoxy-6'-O-desmethylcandidusin B; CHEMBL1801784; CHEBI:67402; DTXSID101214920; BDBM50347542; Q27135864; 3-(4-Hydroxyphenyl)-4-methoxy-1,7,8-dibenzofurantriol; 6-Methoxy-7-(4-hydroxyphenyl)dibenzofuran-2,3,9-triol; 1299485-94-1
|
|
CAS | 1299485-94-1 | |
PubChem CID | 53262759 | |
ChEMBL ID | CHEMBL1801784 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 338.3 | ALogp: | 3.8 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 103.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 25 | QED Weighted: | 0.395 |
Caco-2 Permeability: | -5.153 | MDCK Permeability: | 0.00000895 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.014 |
Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.478 |
30% Bioavailability (F30%): | 0.976 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 95.94% |
Volume Distribution (VD): | 0.536 | Fu: | 6.87% |
CYP1A2-inhibitor: | 0.97 | CYP1A2-substrate: | 0.664 |
CYP2C19-inhibitor: | 0.287 | CYP2C19-substrate: | 0.053 |
CYP2C9-inhibitor: | 0.657 | CYP2C9-substrate: | 0.886 |
CYP2D6-inhibitor: | 0.357 | CYP2D6-substrate: | 0.839 |
CYP3A4-inhibitor: | 0.196 | CYP3A4-substrate: | 0.151 |
Clearance (CL): | 13.908 | Half-life (T1/2): | 0.842 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.092 |
Drug-inuced Liver Injury (DILI): | 0.975 | AMES Toxicity: | 0.754 |
Rat Oral Acute Toxicity: | 0.232 | Maximum Recommended Daily Dose: | 0.757 |
Skin Sensitization: | 0.938 | Carcinogencity: | 0.343 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.922 |
Respiratory Toxicity: | 0.18 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002475 | 0.810 | D04AIT | 0.455 | ||||
ENC005391 | 0.753 | D0K8KX | 0.444 | ||||
ENC002471 | 0.667 | D06GCK | 0.376 | ||||
ENC002853 | 0.602 | D0U3YB | 0.327 | ||||
ENC002756 | 0.598 | D07MGA | 0.323 | ||||
ENC005880 | 0.568 | D0AZ8C | 0.313 | ||||
ENC001998 | 0.549 | D04XEG | 0.310 | ||||
ENC005039 | 0.543 | D0J7RK | 0.307 | ||||
ENC001573 | 0.541 | D06KYN | 0.298 | ||||
ENC002755 | 0.522 | D06TJJ | 0.279 |